Novel therapeutic applications of cardiac glycosides (original) (raw)

• Schatzmann, H. J. & Rass, B. Inhibition of the active Na-K-transport and Na-K-activated membrane ATP-ase of erythrocyte stroma by ouabain. Helv. Physiol. Pharmacol. Acta 65, C47–C49 (1965) (in German).
  CAS PubMed Google Scholar
• Rahimtoola, S. H. & Tak, T. The use of digitalis in heart failure. Curr. Probl. Cardiol. 21, 781–853 (1996).
  CAS PubMed Google Scholar
• Xie, Z. & Askari, A. Na+/K+-ATPase as a signal transducer. Eur. J. Biochem. 269, 2434–2439 (2002).
  CAS PubMed Google Scholar
• Aizman, O. & Aperia, A. Na, K-ATPase as a signal transducer. Ann. NY Acad. Sci. 986, 489–496 (2003).
  CAS PubMed Google Scholar
• Aperia, A. New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J. Intern. Med. 261, 44–52 (2007).
  CAS PubMed Google Scholar
• Kometiani, P., Liu, L. & Askari, A. Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells. Mol. Pharmacol. 67, 929–936 (2005).
  CAS PubMed Google Scholar
• Schoner, W. & Scheiner-Bobis, G. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am. J. Cardiovasc. Drugs 7, 173–189 (2007).
  CAS PubMed Google Scholar
• Schoner, W. & Scheiner-Bobis, G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 293, C509–C536 (2007).
  CAS PubMed Google Scholar
• Schoner, W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur. J. Biochem. 269, 2440–2448 (2002).
  CAS PubMed Google Scholar
• Mijatovic, T. et al. Cardiotonic steroids on the road to anti-cancer therapy. Biochim. Biophys. Acta 1776, 32–57 (2007). An excellent up-to-date review on the anticancer effects of cardiac glycosides.
  CAS PubMed Google Scholar
• Winnicka, K., Bielawski, K. & Bielawska, A. Cardiac glycosides in cancer research and cancer therapy. Acta Pol. Pharm. 63, 109–115 (2006).
  CAS PubMed Google Scholar
• Lopez-Lazaro, M. Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved. Expert. Opin. Ther. Targets. 11, 1043–1053 (2007).
  CAS PubMed Google Scholar
• Mekhail, T. et al. Phase 1 trial of Anvirzel in patients with refractory solid tumors. Invest. New Drugs 24, 423–427 (2006).
  CAS PubMed Google Scholar
• Newman, R. A., Yang, P., Pawlus, A. D. & Block, K. I. Cardiac glycosides as novel cancer therapeutic agents. Mol. Interv. 8, 36–49 (2008).
  CAS PubMed Google Scholar
• Mijatovic, T. et al. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 8, 402–412 (2006).
  CAS PubMed PubMed Central Google Scholar
• Schonfeld, W. et al. The lead structure in cardiac glycosides is 5β,14β-androstane-3β14-diol. Naunyn Schmiedebergs Arch. Pharmacol. 329, 414–426 (1985).
  CAS PubMed Google Scholar
• Melero, C. P., Medardea, M. & Feliciano, A. S. A short review on cardiotonic steroids and their aminoguanidine analogues. Molecules 5, 51–81 (2000).
  CAS Google Scholar
• Langenhan, J. M., Peters, N. R., Guzei, I. A., Hoffmann, F. M. & Thorson, J. S. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc. Natl Acad. Sci. USA 102, 12305–12310 (2005). The first report on neoglycorandomization as a novel high-throughput method to study the relationship between attached sugars and the biological activity of cardiac glycosides.
  CAS PubMed Google Scholar
• Steyn, P. S. & van Heerden, F. R. Bufadienolides of plant and animal origin. Nat. Prod. Rep. 15, 397–413 (1998).
  CAS PubMed Google Scholar
• Mathews, W. R. et al. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 17, 930–935 (1991).
  CAS PubMed Google Scholar
• Goto, A., Yamada, K., Ishii, M. & Sugimoto, T. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance. Am. J. Med. 89, 420–426 (1990).
  CAS PubMed Google Scholar
• Weidemann, H. Na/K-ATPase, endogenous digitalis like compounds and cancer development — a hypothesis. Front. Biosci. 10, 2165–2176 (2005).
  CAS PubMed Google Scholar
• Hamlyn, J. M. et al. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. USA 88, 6259–6263 (1991).
  CAS PubMed Google Scholar
• Schneider, R. et al. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 273, 784–792 (1998).
  CAS PubMed Google Scholar
• Kawamura, A. et al. On the structure of endogenous ouabain. Proc. Natl Acad. Sci. USA 96, 6654–6659 (1999).
  CAS PubMed Google Scholar
• Komiyama, Y. et al. Identification of endogenous ouabain in culture supernatant of PC12 cells. J. Hypertens. 19, 229–236 (2001).
  CAS PubMed Google Scholar
• Lichtstein, D. et al. Identification of digitalis-like compounds in human cataractous lenses. Eur. J. Biochem. 216, 261–268 (1993).
  CAS PubMed Google Scholar
• Bagrov, A. Y. et al. Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31, 1097–1103 (1998).
  CAS PubMed Google Scholar
• Schneider, R. et al. Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure. Clin. Exp. Hypertens. 20, 593–599 (1998).
  CAS PubMed Google Scholar
• Qazzaz, H. M., Cao, Z., Bolanowski, D. D., Clark, B. J. & Valdes, R. Jr. De novo biosynthesis and radiolabeling of mammalian digitalis-like factors. Clin. Chem. 50, 612–620 (2004).
  CAS PubMed Google Scholar
• Kaplan, J. H. Biochemistry of Na, K-ATPase. Annu. Rev. Biochem. 71, 511–535 (2002).
  CAS PubMed Google Scholar
• Smith, T. W. The fundamental mechanism of inotropic action of digitalis. Therapie 44, 431–435 (1989).
  CAS PubMed Google Scholar
• Jorgensen, P. L., Hakansson, K. O. & Karlish, S. J. Structure and mechanism of Na, K-ATPase: functional sites and their interactions. Annu. Rev. Physiol. 65, 817–849 (2003).
  CAS PubMed Google Scholar
• Morth, J. P. et al. Crystal structure of the sodium–potassium pump. Nature 450, 1043–1049 (2007). The X-ray crystal structure of Na+/K+-ATPase resolved at 3.5 Å.
  CAS PubMed Google Scholar
• Qiu, L. Y. et al. Reconstruction of the complete ouabain-binding pocket of Na, K-ATPase in gastric H, K-ATPase by substitution of only seven amino acids. J. Biol. Chem. 280, 32349–32355 (2005).
  CAS PubMed Google Scholar
• Qiu, L. Y. et al. Conversion of the low affinity ouabain-binding site of non-gastric H, K-ATPase into a high affinity binding site by substitution of only five amino acids. J. Biol. Chem. 281, 13533–13539 (2006).
  CAS PubMed Google Scholar
• Dostanic-Larson, I. et al. Physiological role of the α1- and α2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R524–R528 (2006).
  CAS PubMed Google Scholar
• Delprat, B., Bibert, S. & Geering, K. FXYD proteins: novel regulators of Na, K-ATPase. Med. Sci. (Paris) 22, 633–638 (2006) (in French).
  Google Scholar
• Geering, K. Function of FXYD proteins, regulators of Na, K-ATPase. J. Bioenerg. Biomembr. 37, 387–392 (2005).
  CAS PubMed Google Scholar
• Nguyen, A. N., Wallace, D. P. & Blanco, G. Ouabain binds with high affinity to the Na, K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation. J. Am. Soc. Nephrol. 18, 46–57 (2007).
  CAS PubMed Google Scholar
• Blanco, G. Na, K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin. Nephrol. 25, 292–303 (2005).
  CAS PubMed Google Scholar
• Sverdlov, E. D. et al. Na+, K+-ATPase: tissue-specific expression of genes coding for α-subunit in diverse human tissues. FEBS Lett. 239, 65–68 (1988).
  CAS PubMed Google Scholar
• Geering, K. et al. FXYD proteins: new tissue- and isoform-specific regulators of Na, K-ATPase. Ann. NY Acad. Sci. 986, 388–394 (2003).
  CAS PubMed Google Scholar
• Mobasheri, A. et al. Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci. Rep. 20, 51–91 (2000).
  CAS PubMed Google Scholar
• Haas, M., Wang, H., Tian, J. & Xie, Z. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 277, 18694–18702 (2002).
  CAS PubMed Google Scholar
• Haas, M., Askari, A. & Xie, Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J. Biol. Chem. 275, 27832–27837 (2000).
  CAS PubMed Google Scholar
• Yuan, Z. et al. Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol. Biol. Cell 16, 4034–4045 (2005).
  CAS PubMed PubMed Central Google Scholar
• Segall, L., Javaid, Z. Z., Carl, S. L., Lane, L. K. & Blostein, R. Structural basis for α1 versus α2 isoform-distinct behavior of the Na, K-ATPase. J. Biol. Chem. 278, 9027–9034 (2003).
  CAS PubMed Google Scholar
• Liu, L., Abramowitz, J., Askari, A. & Allen, J. C. Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype. Am. J. Physiol. Heart Circ. Physiol. 287, H2173–H2182 (2004).
  CAS PubMed Google Scholar
• Barwe, S. P. et al. Novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol. Biol. Cell 16, 1082–1094 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. Q. et al. Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J. Cell Sci. 116, 2099–2110 (2003).
  CAS PubMed Google Scholar
• Aizman, O., Uhlen, P., Lal, M., Brismar, H. & Aperia, A. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc. Natl Acad. Sci. USA 98, 13420–13424 (2001).
  CAS PubMed Google Scholar
• Saunders, R. & Scheiner-Bobis, G. Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump. Eur. J. Biochem. 271, 1054–1062 (2004).
  CAS PubMed Google Scholar
• Zhang, S. et al. Distinct role of the N-terminal tail of the Na, K-ATPase catalytic subunit as a signal transducer. J. Biol. Chem. 281, 21954–21962 (2006).
  CAS PubMed Google Scholar
• Liang, M., Cai, T., Tian, J., Qu, W. & Xie, Z. J. Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J. Biol. Chem. 281, 19709–19719 (2006).
  CAS PubMed Google Scholar
• Dolmetsch, R. E., Xu, K. & Lewis, R. S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392, 933–936 (1998).
  CAS Google Scholar
• Li, J., Zelenin, S., Aperia, A. & Aizman, O. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-κB. J. Am. Soc. Nephrol. 17, 1848–1857 (2006).
  CAS PubMed Google Scholar
• Xie, Z. & Cai, T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 3, 157–168 (2003). An excellent review of the signalling properties of the sodium pump, which emphasizes the structural and functional characteristics of the signalosome domain.
  CAS PubMed Google Scholar
• Tian, J., Liu, J., Garlid, K. D., Shapiro, J. I. & Xie, Z. Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial KATP channels. Mol. Cell Biochem. 242, 181–187 (2003).
  CAS PubMed Google Scholar
• Yudowski, G. A. et al. Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc. Natl Acad. Sci. USA 97, 6556–6561 (2000).
  CAS PubMed Google Scholar
• Eva, A., Kirch, U. & Scheiner-Bobis, G. Signaling pathways involving the sodium pump stimulate NO production in endothelial cells. Biochim. Biophys. Acta 1758, 1809–1814 (2006).
  CAS PubMed Google Scholar
• Xie, Z. et al. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J. Biol. Chem. 274, 19323–19328 (1999).
  CAS PubMed Google Scholar
• Baudouin-Legros, M., Brouillard, F., Tondelier, D., Hinzpeter, A. & Edelman, A. Effect of ouabain on CFTR gene expression in human Calu-3 cells. Am. J. Physiol. Cell Physiol. 284, C620–C626 (2003).
  CAS PubMed Google Scholar
• Contreras, R. G., Shoshani, L., Flores-Maldonado, C., Lazaro, A. & Cereijido, M. Relationship between Na+, K+-ATPase and cell attachment. J. Cell Sci. 112, 4223–4232 (1999).
  CAS PubMed Google Scholar
• Rajasekaran, S. A. et al. Na, K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol. Biol. Cell 12, 3717–3732 (2001).
  CAS PubMed PubMed Central Google Scholar
• Wang, L., Wible, B. A., Wan, X. & Ficker, E. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking. J. Pharmacol. Exp. Ther. 320, 525–534 (2007).
  CAS PubMed Google Scholar
• Abramowitz, J. et al. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5. Circulation 108, 3048–3053 (2003).
  CAS PubMed Google Scholar
• Aydemir-Koksoy, A., Abramowitz, J. & Allen, J. C. Ouabain-induced signaling and vascular smooth muscle cell proliferation. J. Biol. Chem. 276, 46605–46611 (2001).
  CAS PubMed Google Scholar
• Stenkvist, B. et al. Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal. Quant. Cytol. 2, 49–54 (1980).
  CAS PubMed Google Scholar
• Stenkvist, B. et al. Cardiac glycosides and breast cancer. Lancet 1, 563 (1979).
  CAS PubMed Google Scholar
• Stenkvist, B. et al. Cardiac glycosides and breast cancer, revisited. N. Engl. J. Med. 306, 484 (1982). The first epidemiological report on the anticancer effects of cardiac glycosides.
  CAS PubMed Google Scholar
• Goldin, A. G. & Safa, A. R. Digitalis and cancer. Lancet 1, 1134 (1984).
  CAS PubMed Google Scholar
• Stenkvist, B. Is digitalis a therapy for breast carcinoma? Oncol. Rep. 6, 493–496 (1999).
  CAS PubMed Google Scholar
• Haux, J., Klepp, O., Spigset, O. & Tretli, S. Digitoxin medication and cancer; case control and internal dose–response studies. BMC Cancer 1, 11 (2001).
  CAS PubMed PubMed Central Google Scholar
• Haux, J. Digitoxin is a potential anticancer agent for several types of cancer. Med. Hypotheses 53, 543–548 (1999). The first analytical description of the in vivo antineoplastic properties of digitoxin against several cancer cell lines.
  CAS PubMed Google Scholar
• Shiratori, O. Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies. Gann 58, 521–528 (1967).
  CAS PubMed Google Scholar
• Bielawski, K., Winnicka, K. & Bielawska, A. Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol. Pharm. Bull. 29, 1493–1497 (2006).
  CAS PubMed Google Scholar
• Lopez-Lazaro, M. et al. Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J. Nat. Prod. 68, 1642–1645 (2005).
  CAS PubMed Google Scholar
• McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z. & Newman, R. A. Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res. 60, 3807–3812 (2000).
  CAS PubMed Google Scholar
• Huang, Y. T., Chueh, S. C., Teng, C. M. & Guh, J. H. Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells. Biochem. Pharmacol. 67, 727–733 (2004).
  CAS PubMed Google Scholar
• Yeh, J. Y., Huang, W. J., Kan, S. F. & Wang, P. S. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 54, 112–124 (2003).
  CAS PubMed Google Scholar
• Newman, R. A. et al. Oleandrin-mediated oxidative stress in human melanoma cells. J. Exp. Ther. Oncol. 5, 167–181 (2006).
  CAS PubMed Google Scholar
• Newman, R. A. et al. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Integr. Cancer Ther. 6, 354–364 (2007).
  CAS PubMed Google Scholar
• Mijatovic, T. et al. The cardenolide UNBS1450 is able to deactivate nuclear factor κB-mediated cytoprotective effects in human non-small cell lung cancer cells. Mol. Cancer Ther. 5, 391–399 (2006). The first report on UNBS 1450, a novel cardiac glycoside derivative with improved anticancer properties.
  CAS PubMed Google Scholar
• Frese, S. et al. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res. 66, 5867–5874 (2006).
  CAS PubMed Google Scholar
• Raghavendra, P. B., Sreenivasan, Y., Ramesh, G. T. & Manna, S. K. Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases. Apoptosis 12, 307–318 (2007).
  CAS PubMed PubMed Central Google Scholar
• Masuda, Y. et al. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk. Res. 19, 549–556 (1995).
  CAS PubMed Google Scholar
• Daniel, D., Susal, C., Kopp, B., Opelz, G. & Terness, P. Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives. Int. Immunopharmacol. 3, 1791–1801 (2003).
  CAS PubMed Google Scholar
• Jing, Y. et al. Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn. J. Cancer Res. 85, 645–651 (1994).
  CAS PubMed PubMed Central Google Scholar
• Kawazoe, N., Watabe, M., Masuda, Y., Nakajo, S. & Nakaya, K. Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene 18, 2413–2421 (1999).
  CAS PubMed Google Scholar
• Watabe, M., Kawazoe, N., Masuda, Y., Nakajo, S. & Nakaya, K. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells. Cancer Res. 57, 3097–3100 (1997).
  CAS PubMed Google Scholar
• Kulikov, A., Eva, A., Kirch, U., Boldyrev, A. & Scheiner-Bobis, G. Ouabain activates signaling pathways associated with cell death in human neuroblastoma. Biochim. Biophys. Acta 1768, 1691–1702 (2007).
  CAS PubMed Google Scholar
• Johansson, S. et al. Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs 12, 475–483 (2001).
  CAS PubMed Google Scholar
• Van Quaquebeke, E. et al. 2,2,2-Trichloro-_N_-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1_H_-be nzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. J. Med. Chem. 50, 4122–4134 (2007).
  CAS PubMed Google Scholar
• Johnson, P. H. et al. Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Mol. Cancer Ther. 1, 1293–1304 (2002).
  CAS PubMed Google Scholar
• Smith, J. A., Madden, T., Vijjeswarapu, M. & Newman, R. A. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem. Pharmacol. 62, 469–472 (2001).
  CAS PubMed Google Scholar
• Manna, S. K., Sreenivasan, Y. & Sarkar, A. Cardiac glycoside inhibits IL-8-induced biological responses by downregulating IL-8 receptors through altering membrane fluidity. J. Cell Physiol. 207, 195–207 (2006).
  CAS PubMed Google Scholar
• Lawrence, T. S. Ouabain sensitizes tumor cells but not normal cells to radiation. Int. J. Radiat. Oncol. Biol. Phys. 15, 953–958 (1988).
  CAS PubMed Google Scholar
• Verheye-Dua, F. & Bohm, L. Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines. Radiat. Oncol. Investig. 6, 109–119 (1998).
  CAS PubMed Google Scholar
• Nasu, S., Milas, L., Kawabe, S., Raju, U. & Newman, R. Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process. Cancer Lett. 185, 145–151 (2002).
  CAS PubMed Google Scholar
• Inada, A. et al. Anti-tumor promoting activities of natural products. II. Inhibitory effects of digitoxin on two-stage carcinogenesis of mouse skin tumors and mouse pulmonary tumors. Biol. Pharm. Bull. 16, 930–931 (1993).
  CAS PubMed Google Scholar
• Afaq, F., Saleem, M., Aziz, M. H. & Mukhtar, H. Inhibition of 12-_O_-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin. Toxicol. Appl. Pharmacol. 195, 361–369 (2004).
  CAS PubMed Google Scholar
• Svensson, A., Azarbayjani, F., Backman, U., Matsumoto, T. & Christofferson, R. Digoxin inhibits neuroblastoma tumor growth in mice. Anticancer Res. 25, 207–212 (2005).
  CAS PubMed Google Scholar
• Han, K. Q. et al. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J. Gastroenterol. 13, 3374–3379 (2007).
  CAS PubMed PubMed Central Google Scholar
• Pathak, S., Multani, A. S., Narayan, S., Kumar, V. & Newman, R. A. Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs 11, 455–463 (2000).
  CAS PubMed Google Scholar
• Ahmed, A. et al. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int. J. Cardiol. 123, 138–146 (2008).
  PubMed Google Scholar
• Mohammadi, K., Kometiani, P., Xie, Z. & Askari, A. Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2. J. Biol. Chem. 276, 42050–42056 (2001).
  CAS PubMed Google Scholar
• Gjesdal, K., Feyzi, J. & Olsson, S. B. Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data. Heart 94, 191–196 (2008).
  CAS PubMed Google Scholar
• Simpson, R. J. Jr. Assessing the safety of drugs through observational research. Heart 94, 129–130 (2008).
  PubMed Google Scholar
• Srivastava, M. et al. Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc. Natl Acad. Sci. USA 101, 7693–7698 (2004).
  CAS PubMed Google Scholar
• Wang, J. K. et al. Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Proc. Natl Acad. Sci. USA 103, 10461–10466 (2006). The first report on the neuroprotective effects of cardiac glycosides against ischaemic stroke.
  CAS PubMed Google Scholar
• Pierre, S. V. et al. Ouabain triggers preconditioning through activation of the Na+, K+-ATPase signaling cascade in rat hearts. Cardiovasc. Res. 73, 488–496 (2007).
  CAS PubMed Google Scholar
• Piccioni, F., Roman, B. R., Fischbeck, K. H. & Taylor, J. P. A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor. Hum. Mol. Genet. 13, 437–446 (2004).
  CAS PubMed Google Scholar
• Nesher, M., Shpolansky, U., Rosen, H. & Lichtstein, D. The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci. 80, 2093–2107 (2007).
  CAS PubMed Google Scholar
• Scheiner-Bobis, G. & Schoner, W. A fresh facet for ouabain action. Nature Med. 7, 1288–1289 (2001).
  CAS PubMed Google Scholar
• Kaplan, J. H. The sodium pump and hypertension: a physiological role for the cardiac glycoside binding site of the Na, K-ATPase. Proc. Natl. Acad. Sci. USA 102, 15723–15724 (2005).
  CAS PubMed Google Scholar
• Dostanic-Larson, I., Van Huysse, J. W., Lorenz, J. N. & Lingrel, J. B. The highly conserved cardiac glycoside binding site of Na, K-ATPase plays a role in blood pressure regulation. Proc. Natl Acad. Sci. USA 102, 15845–15850 (2005).
  CAS PubMed Google Scholar
• Kaplan, J. G. Membrane cation transport and the control of proliferation of mammalian cells. Annu. Rev. Physiol. 40, 19–41 (1978).
  CAS PubMed Google Scholar
• Espineda, C. et al. Analysis of the Na, K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 97, 1859–1868 (2003).
  CAS PubMed Google Scholar
• Lee, S. et al. Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays. Cancer Lett. 184, 197–206 (2002).
  CAS PubMed Google Scholar
• Sakai, H. et al. Up-regulation of Na+, K+-ATPase α3-isoform and down-regulation of the α1-isoform in human colorectal cancer. FEBS Lett. 563, 151–154 (2004).
  CAS PubMed Google Scholar
• Mijatovic, T. et al. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J. Pathol. 212, 170–179 (2007).
  CAS PubMed Google Scholar
• Chen, J. Q. et al. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs? Breast Cancer Res. Treat. 96, 1–15 (2006).
  CAS PubMed Google Scholar
• Hashimoto, S. et al. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk. Res. 21, 875–883 (1997).
  CAS PubMed Google Scholar
• Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891–899 (2004).
  CAS Google Scholar
• Gatenby, R. A. & Gillies, R. J. Glycolysis in cancer: a potential target for therapy. Int. J. Biochem. Cell Biol. 39, 1358–1366 (2007).
  CAS PubMed Google Scholar
• Garber, K. Energy deregulation: licensing tumors to grow. Science 312, 1158–1159 (2006).
  CAS PubMed Google Scholar
• Pelicano, H., Martin, D. S., Xu, R. H. & Huang, P. Glycolysis inhibition for anticancer treatment. Oncogene 25, 4633–4646 (2006).
  CAS PubMed Google Scholar
• Isidoro, A. et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem. J. 378, 17–20 (2004).
  CAS PubMed PubMed Central Google Scholar
• Rhee, S. G., Yang, K. S., Kang, S. W., Woo, H. A. & Chang, T. S. Controlled elimination of intracellular H2O2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox. Signal. 7, 619–626 (2005).
  CAS PubMed Google Scholar
• Paul, R. J., Bauer, M. & Pease, W. Vascular smooth muscle: aerobic glycolysis linked to sodium and potassium transport processes. Science 206, 1414–1416 (1979).
  CAS PubMed Google Scholar
• Zavareh, R. B. et al.Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. Cancer Res. 68, 6688–6697 (2008).
  CAS Google Scholar